In patients with muscle-invasive bladder cancer, smoking cigarettes was associated with poor response to cisplatin-based chemotherapy, found new study published in BJU International.
The study included 58 never smokers, 87 former smokers, and 56 current smokers.
Cigarette Smoking - A Silent Killer
Smoking kills the smoker silently, pushing him towards serious illnesses, which slowly lead to death.
Advertisement
‘Physicians should have a proactive role in educating patients regarding the detrimental effect of smoking on cancer-specific and overall health outcomes. ’
Tweet it Now
Additional research is needed to assess the impact of smoking and smoking cessation on survival in patients treated for muscle-invasive bladder cancer.
Source: Eurekalert
Bladder Cancer
Bladder cancer occurs due to abnormal cell growth in the urinary bladder. The most common kind usually is urothelial cancer or transitional cell carcinoma.
Advertisement
 Quiz on SmokingApproximately half the smokers die due to smoking -related diseases. But it is not just the smokers who are at the receiving end. The passive smokers too, often pay a heavy price. If you still have not 'kicked the butt', learn more horrifying facts about smoking by participating in the following quiz. | Advertisement
|
Chemotherapy Regimens for Best Outcomes in Invasive Bladder Cancer Compared
Patients with muscle-invasive bladder cancer have been shown to benefit from chemotherapy prior to surgical removal of the bladder.
Advertisement
Recommended Readings
Latest Cancer News
The new study uncovers the efficacy of fixed-duration combination treatment in patients with high-risk leukemia.
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable